DNA Spheres Light Up to Detect Cancer

Ball-shaped molecules release flares when they encounter malignancy

Join Our Community of Science Lovers!

Cancer travels. Large tumors shed cells that move through the body and seed new malignancies. Now scientists are tinkering on the nanoscale to build unusual spheres made of DNA—a molecule that became famous as another shape, the double helix—that can find, tag and potentially kill off these tumor cells.

The spheres look a bit like toothpicks stuck in a small Styrofoam ball. The toothpicks are really a dense crowd of single DNA strands jutting out from a central core. The strands are chosen for their ability to bind to complementary DNA in cancer cells. When a bond happens, it displaces tiny light-emitting molecules stuck to the tips of the DNA in the sphere, essentially sending up a flare that indicates the presence of cancer. The brighter the flare, the more cancer DNA that is present, says Chad A. Mirkin, a chemist and director of the International Institute for Nanotechnology at Northwestern University, who has spearheaded the research.

These encounters occur in a sample of a patient's blood. When the spheres run into a cell, they move through pores in the cell membrane into the interior. There, the DNA that forms that outer rim has a much higher chance of encountering and latching on to cancer DNA than isolated strands would.* Spherical nucleic acids “bind to other nucleic acids 100 times more strongly,” Mirkin says.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Mirkin's spheres, also called Nanoflares, are already being used by hospitals for rapid cancer diagnosis. Other systems fish out dead tumor cells based on proteins on their outer surfaces, but because these spheres identify live cells, Mirkin says, scientists could test how the cells respond to different drugs and eventually develop personalized treatments based on the results.

*Editor's Note (6/2/15): This sentence was edited after it was posted online to remove an error that appeared in the original print version.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe